Top

Published in:

01-04-2011 | Review

Bariatric Surgery and Renal Function

Authors: Andrew Currie, Andrew Chetwood, Ahmed R. Ahmed

Published in: Obesity Surgery | Issue 4/2011

Abstract

Obesity causes a significant healthcare burden and has been shown to be an important risk factor in the development of cardiovascular disease, type 2 diabetes, and increasingly chronic kidney disease. Bariatric surgery is the most effective treatment for obesity and has been shown to drastically improve both blood pressure and diabetic control. However, the interaction of bariatric surgery and renal function is less clear. This review focuses on the effect of bariatric surgery on renal function both in the acute situation, with respect to acute kidney injury, and also on changes in renal function parameters post-bariatric surgery weight loss. The interaction of obesity, bariatric surgery, and nephrolithiasis as a precipitant of acute kidney injury will also be considered. The role of bariatric surgery in pre- and post-renal transplant recipients is discussed as well as possible mechanisms underlying the improvement in renal function.

Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295(13):1549–55.PubMed

Hu FB, Willett WC, Li T, et al. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med. 2004;351(26):2694–703.PubMed

Yan LL, Daviglus ML, Liu K, et al. Midlife body mass index and hospitalization and mortality in older age. JAMA. 2006;295(2):190–8.PubMed

Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol. 2007;2(3):550–62.PubMed

Wang Y, Chen X, Song Y, et al. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008;73(1):19–33.PubMed

Fox CS. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291(7):844–50.PubMed

Hsu CY, Iribarren C, McCulloch CE, et al. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2009;169(4):342–50.PubMed

Jafar TH, Stark PC, Schmid CH, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med. 2003;139(4):244–52.PubMed

Jafar TH, Schmid CH, Landa M, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001;135(2):73–87.PubMed

10.

Praga M, Morales E. Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens. 2006;15(5):481–6.PubMed

11.

Hinojosa MW, Varela JE, Parikh D, et al. National trends in use and outcome of laparoscopic adjustable gastric banding. Surg Obes Relat Dis. 2009;5(2):150–5.PubMed

12.

Kramer H, Tuttle KR, Leehey D, et al. Obesity management in adults with CKD. Am J Kidney Dis. 2009;53(1):151–65.PubMed

13.

Afshinnia F, Wilt TJ, Duval S, et al. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant. 2010;25(4):1173–83.PubMed

14.

Brinkworth GD, Buckley JD, Noakes M, et al. Renal function following long-term weight loss in individuals with abdominal obesity on a very low-carbohydrate diet vs. high-carbohydrate diet. J Am Diet Assoc. 2010;110(4):633–8.PubMed

15.

Ahmed MH, Byrne CD. Bariatric surgery and renal function: a precarious balance between benefit and harm. Nephrol Dial Transplant. 2010;25(10):3142–7.PubMed

16.

Navaneethan SD, Yehnert H. Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis. 2009;5(6):662–5.PubMed

17.

Zalesin KC, McCullough PA. Bariatric surgery for morbid obesity: risks and benefits in chronic kidney disease patients. Adv Chron Kidney Dis. 2006;13(4):403–17.

18.

Serra A, Granada ML, Romero R, et al. The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clin Nutr. 2006;25(3):400–8.PubMed

19.

Navarro-Diaz M, Serra A, Romero R, et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol. 2006;17(12 Suppl 3):S213–7.PubMed

20.

Agrawal V, Khan I, Rai B, et al. The effect of weight loss after bariatric surgery on albuminuria. Clin Nephrol. 2008;70(3):194–202.PubMed

21.

Saliba J, Kasim NR, Tamboli RA, et al. Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics. Surgery. 2010;147(2):282–7.PubMed

22.

Chagnac A, Weinstein T, Herman M, et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol. 2003;14(6):1480–6.PubMed

23.

Alexander JW, Goodman HR, Hawver LR, et al. Improvement and stabilization of chronic kidney disease after gastric bypass. Surg Obes Relat Dis. 2009;5(2):237–41.PubMed

24.

Izzedine H, Coupaye M, Reach I, et al. Gastric bypass and resolution of proteinuria in an obese diabetic patient. Diabet Med. 2005;22(12):1761–2.PubMed

25.

Cuda SP, Chung MH, Denunzio TM, et al. Reduction of proteinuria after gastric bypass surgery: case presentation and management. Surg Obes Relat Dis. 2005;1(1):64–6.PubMed

26.

Fowler SM, Kon V, Ma L, et al. Obesity-related focal and segmental glomerulosclerosis: normalization of proteinuria in an adolescent after bariatric surgery. Pediatr Nephrol. 2009;24(4):851–5.PubMed

27.

Agnani S, Vachharajani VT, Gupta R, et al. Does treating obesity stabilize chronic kidney disease? BMC Nephrol. 2005;6(1):7.PubMed

28.

Soto FC, Higa-Sansone G, Copley JB, et al. Renal failure, glomerulonephritis and morbid obesity: improvement after rapid weight loss following laparoscopic gastric bypass. Obes Surg. 2005;15(1):137–40.PubMed

29.

Tafti BA, Haghdoost M, Alvarez L, et al. Recovery of renal function in a dialysis-dependent patient following gastric bypass surgery. Obes Surg. 2009;19(9):1335–9.PubMed

30.

Thakar CV, Kharat V, Blanck S, et al. Acute kidney injury after gastric bypass surgery. Clin J Am Soc Nephrol. 2007;2(3):426–30.PubMed

31.

Bostanjian D, Anthone GJ, Hamoui N, et al. Rhabdomyolysis of gluteal muscles leading to renal failure: a potentially fatal complication of surgery in the morbidly obese. Obes Surg. 2003;13(2):302–5.PubMed

32.

Khurana RN, Baudendistel TE, Morgan EF, et al. Postoperative rhabdomyolysis following laparoscopic gastric bypass in the morbidly obese. Arch Surg. 2004;139(1):73–6.PubMed

33.

Wiltshire JP, Custer T. Lumbar muscle rhabdomyolysis as a cause of acute renal failure after Roux-en-Y gastric bypass. Obes Surg. 2003;13(2):306–13.PubMed

34.

de Oliveira LD, Diniz MT, de Fatima HSDM, et al. Rhabdomyolysis after bariatric surgery by Roux-en-Y gastric bypass: a prospective study. Obes Surg. 2009;19(8):1102–7.PubMed

35.

Mognol P, Vignes S, Chosidow D, et al. Rhabdomyolysis after laparoscopic bariatric surgery. Obes Surg. 2004;14(1):91–4.PubMed

36.

Lagandre S, Arnalsteen L, Vallet B, et al. Predictive factors for rhabdomyolysis after bariatric surgery. Obes Surg. 2006;16(10):1365–70.PubMed

37.

Carvalho DAD, Valezi AC, de Brito EM, et al. Rhabdomyolysis after bariatric surgery. Obes Surg. 2006;16(6):740–4.

38.

Ettinger JEMTD, dos Santos PV, Azaro E, et al. Prevention of rhabdomyolysis in bariatric surgery. Obes Surg. 2005;15(6):874–9.

39.

Pasnik K, Krupa J, Stanowski E, et al. Successful treatment of gastric fistula following rhabdomyolysis after vertical banded gastroplasty. Obes Surg. 2005;15(3):428–30.PubMed

40.

Stroh C, Hohmann U, Remmler K, et al. Rhabdomyolysis after biliopancreatic diversion with duodenal switch. Obes Surg. 2005;15(9):1347–51.PubMed

41.

Nasr SH, D’Agati VD, Said SM, et al. Oxalate nephropathy complicating Roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol. 2008;3(6):1676–83.PubMed

42.

Curhan GC, Willett WC, Rimm EB, et al. Body size and risk of kidney stones. J Am Soc Nephrol. 1998;9(9):1645–52.PubMed

43.

Semins MJ, Shore AD, Makary MA, et al. The association of increasing body mass index and kidney stone disease. J Urol. 2010;183(2):571–5.PubMed

44.

Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293(4):455–62.PubMed

45.

Powell CR, Stoller ML, Schwartz BF, et al. Impact of body weight on urinary electrolytes in urinary stone formers. Urology. 2000;55(6):825–30.PubMed

46.

Lieske JC, Kumar R, Collazo-Clavell ML. Nephrolithiasis after bariatric surgery for obesity. Semin Nephrol. 2008;28(2):163–73.PubMed

47.

Mole DR, Tomson CR, Mortensen N, et al. Renal complications of jejuno-ileal bypass for obesity. QJM. 2001;94(2):69–77.PubMed

48.

Requarth JA, Burchard KW, Colacchio TA, et al. Long-term morbidity following jejunoileal bypass. The continuing potential need for surgical reversal. Arch Surg. 1995;130(3):318–25.PubMed

49.

Nordenvall B, Backman L, Larsson L. Oxalate metabolism after intestinal bypass operations. Scand J Gastroenterol. 1981;16(3):395–9.PubMed

50.

Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007;177(2):565–9.PubMed

51.

Patel BN, Passman CM, Fernandez A, et al. Prevalence of hyperoxaluria after bariatric surgery. J Urol. 2009;181(1):161–6.PubMed

52.

Maalouf NM, Tondapu P, Guth ES, et al. Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery. J Urol. 2010;183(3):1026–30.PubMed

53.

Duffey BG, Pedro RN, Makhlouf A, et al. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis. J Am Coll Surg. 2008;206(3):1145–53.PubMed

54.

Duffey BG, Alanee S, Pedro RN, et al. Hyperoxaluria is a long-term consequence of Roux-en-Y gastric bypass: a 2-year prospective longitudinal study. J Am Coll Surg. 2010;211(1):8–15.PubMed

55.

Matlaga BR, Shore AD, Magnuson T, et al. Effect of gastric bypass surgery on kidney stone disease. J Urol. 2009;181(6):2573–7.PubMed

56.

Semins MJ, Asplin JR, Steele K, et al. The effect of restrictive bariatric surgery on urinary stone risk factors. Urology. 2010;76(4):826–9.PubMed

57.

Semins MJ, Matlaga BR, Shore AD, et al. The effect of gastric banding on kidney stone disease. Urology. 2009;74(4):746–9.PubMed

58.

Penniston KL, Kaplon DM, Gould JC, et al. Gastric band placement for obesity is not associated with increased urinary risk of urolithiasis compared to bypass. J Urol. 2009;182(5):2340–6.PubMed

59.

Mittal RD, Kumar R, Bid HK, et al. Effect of antibiotics on Oxalobacter formigenes colonization of human gastrointestinal tract. J Endourol. 2005;19(1):102–6.PubMed

60.

Mittal RD, Kumar R. Gut-inhabiting bacterium Oxalobacter formigenes: role in calcium oxalate urolithiasis. J Endourol. 2004;18(5):418–24.PubMed

61.

Allison MJ, Cook HM, Milne DB, et al. Oxalate degradation by gastrointestinal bacteria from humans. J Nutr. 1986;116(3):455–60.PubMed

62.

Hoppe B, Beck B, Gatter N, et al. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int. 2006;70(7):1305–11.PubMed

63.

Whitson JM, Stackhouse GB, Stoller ML. Hyperoxaluria after modern bariatric surgery: case series and literature review. Int Urol Nephrol. 2010;42(2):369–74.PubMed

64.

Salahudeen AK. Obesity and survival on dialysis. Am J Kidney Dis. 2003;41(5):925–32.PubMed

65.

Degoulet P, Legrain M, Reach I, et al. Mortality risk-factors in patients treated by chronic hemodialysis—report of the Diaphane Collaborative Study. Nephron. 1982;31(2):103–10.PubMed

66.

Fleischmann E, Teal N, Dudley J, et al. Influence of excess weight on mortality and hospital stay in 1,346 hemodialysis patients. Kidney Int. 1999;55(4):1560–7.PubMed

67.

Johansen KL, Young B, Kaysen GA, et al. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr. 2004;80(2):324–32.PubMed

68.

Kalantar-Zadeh K, Abbott KC, Salahudeen AK, et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81(3):543–54.PubMed

69.

Combe C, Chauveau P, Laville M, et al. Influence of nutritional factors and hemodialysis adequacy on the survival of 1,610 French patients. Am J Kidney Dis. 2001;37(1):S81–8.PubMed

70.

Caravaca F, Martin MV, Barroso S, et al. Obesity and mortality in advanced chronic renal failure patients. Nefrologia. 2004;24(5):453–62.PubMed

71.

Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation. 2002;73(1):70–4.PubMed

72.

Armstrong KA, Campbell SB, Hawley CM, et al. Impact of obesity on renal transplant outcomes. Nephrology. 2005;10(4):405–13.PubMed

73.

Bennett WM, McEvoy KM, Henell KR, et al. Morbid obesity does not preclude successful renal transplantation. Clin Transplant. 2004;18(1):89–93.PubMed

74.

Marks WH, Florence LS, Chapman PH, et al. Morbid obesity is not a contraindication to kidney transplantation. Am J Surg. 2004;187(5):635–8.PubMed

75.

El-Agroudy AE, Wafa EW, Gheith OE, et al. Weight gain after renal transplantation is a risk factor for patient and graft outcome. Transplantation. 2004;77(9):1381–5.PubMed

76.

Gore JL. Obesity and renal transplantation: is bariatric surgery the answer? Transplantation. 2009;87(8):1115.PubMed

77.

Takata MC, Campos GM, Ciovica R, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis. 2008;4(2):159–64.PubMed

78.

Modanlou KA, Muthyala U, Xiao HL, et al. Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States Renal Data System and Literature Review. Transplantation. 2009;87(8):1167–73.PubMed

79.

Lopez Deogracias M, Dominguez-Diez A, Palomar-Fontanet R, et al. Biliopancreatic diversion in a renal transplant patient. Obes Surg. 2007;17(4):553–5.PubMed

80.

Ribstein J, Halimi JM, du Cailar G, et al. Renal characteristics and effect of angiotensin suppression in oral contraceptive users. Hypertension. 1999;33(1):90–5.PubMed

81.

Metcalf P, Baker J, Scott A, et al. Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. Clin Chem. 1992;38(9):1802–8.PubMed

82.

Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15(11):2792–800.PubMed

83.

Serradeil-Le Gal C, Raufaste D, Brossard G, et al. Characterization and localization of leptin receptors in the rat kidney. FEBS Lett. 1997;404(2–3):185–91.PubMed

84.

Wolf G, Hamann A, Han DC, et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [see comments]. Kidney Int. 1999;56(3):860–72.PubMed

85.

Esposito K, Giugliano G, Scuderi N, et al. Role of adipokines in the obesity-inflammation relationship: the effect of fat removal. Plast Reconstr Surg. 2006;118(4):1048–57. discussion 58-9.PubMed

86.

Sharma K, Ramachandrarao S, Qiu G, et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest. 2008;118(5):1645–56.PubMed

87.

Zhang XL, Topley N, Ito T, et al. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. J Biol Chem. 2005;280(13):12239–45.PubMed

88.

Abrass CK. Cellular lipid metabolism and the role of lipids in progressive renal disease. Am J Nephrol. 2004;24(1):46–53.PubMed

89.

Weinberg JM. Lipotoxicity. Kidney Int. 2006;70(9):1560–6.PubMed

90.

Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109(9):1125–31.PubMed

91.

Jiang T, Liebman SE, Lucia MS, et al. Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease. Kidney Int. 2005;68(6):2608–20.PubMed

92.

Jiang T, Wang Z, Proctor G, et al. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem. 2005;280(37):32317–25.PubMed

93.

Nishida Y, Yorioka N, Oda H, et al. Effect of lipoproteins on cultured human mesangial cells. Am J Kidney Dis. 1997;29(6):919–30.PubMed

94.

Song CY, Kim BC, Hong HK, et al. Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-beta signaling in mesangial cells. Kidney Int. 2005;67(5):1743–52.PubMed

95.

Nishida Y, Oda H, Yorioka N. Effect of lipoproteins on mesangial cell proliferation. Kidney Int Suppl. 1999;71:S51–3.PubMed

96.

Montani JP, Antic V, Yang Z, et al. Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord. 2002;26 Suppl 2:S28–38.PubMed

97.

Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Ren Physiol. 2000;278(5):F817–22.

98.

Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59(4):1498–509.PubMed

99.

Licata G, Volpe M, Scaglione R, et al. Salt-regulating hormones in young normotensive obese subjects. Effects of saline load. Hypertension. 1994;23(1 Suppl):I20–4.PubMed

100.

Hall JE, Henegar JR, Dwyer TM, et al. Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther. 2004;11(1):41–54.PubMed

101.

Varela JE, Hinojosa M, Nguyen N. Correlations between intra-abdominal pressure and obesity-related co-morbidities. Surg Obes Relat Dis. 2009;5(5):524–8.PubMed

102.

Sugerman HJ. Increased intra-abdominal pressure in obesity. Int J Obes Relat Metab Disord. 1998;22(11):1138.PubMed

103.

Malbrain ML, Cheatham ML, Kirkpatrick A, et al. Results from the international conference of experts on intra-abdominal hypertension and abdominal compartment syndrome. I. Definitions. Intensive Care Med. 2006;32(11):1722–32.PubMed

104.

Sugrue M, Balogh Z, Malbrain M. Intra-abdominal hypertension and renal failure. ANZ J Surg. 2004;74(1–2):78. discussion.PubMed

105.

Sugrue M, Jones F, Deane SA, et al. Intra-abdominal hypertension is an independent cause of postoperative renal impairment. Arch Surg. 1999;134(10):1082–5.PubMed

106.

Bradley SE, Bradley GP. The effect of increased intra abdominal pressure on renal function in man. J Clin Investig. 1947;26(5):1010–22.

107.

Harman PK, Kron IL, Mclachlan HD, et al. Elevated intra-abdominal pressure and renal function. Ann Surg. 1982;196(5):594–7.PubMed

108.

Doty JM, Saggi BH, Blocher CR, et al. Effects of increased renal parenchymal pressure on renal function. J Trauma Inj Infect Crit Care. 2000;48(5):874–7.

109.

Doty JM, Saggi BH, Sugerman HJ, et al. Effect of increased renal venous pressure on renal function. J Trauma Inj Infect Crit Care. 1999;47(6):1000–3.

110.

De laet I, Malbrain ML, Jadoul JL, et al. Renal implications of increased intra-abdominal pressure: are the kidneys the canary for abdominal hypertension? Acta Clin Belg Suppl. 2007;1:119–30.PubMed

111.

Georgaki-Angelaki H, Stergiou N, Manolaki N, et al. Histological deterioration of obesity-related glomerulopathy despite the loss of proteinuria with weight reduction. Pediatr Nephrol. 2010;25(8):1573–4.PubMed

112.

Praga M, Hernandez E, Morales E, et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2001;16(9):1790–8.PubMed

113.

D’Agati VD, Fogo AB, Bruijn JA, et al. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004;43(2):368–82.PubMed

114.

Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982;307(11):652–9.PubMed

115.

Griffin KA, Kramer H, Bidani AK. Adverse renal consequences of obesity. Am J Physiol Ren Physiol. 2008;294(4):F685–96.

Title: Bariatric Surgery and Renal Function
Authors: Andrew Currie
Andrew Chetwood
Ahmed R. Ahmed
Publication date: 01-04-2011
Publisher: Springer-Verlag
Published in: Obesity Surgery / Issue 4/2011
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-011-0356-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Bariatric Surgery and Renal Function

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2011

The Four Different Types of Internal Hernia Occurring After Laparascopic Roux-en-Y Gastric Bypass Performed for Morbid Obesity: Are There Any Multidetector Computed Tomography (MDCT) Features Permitting Their Distinction?

Early and Late Abdominal Bleeding After Roux-en-Y Gastric Bypass: Sources and Tailored Therapeutic Strategies

The Potential Role of Intragastric Balloon in the Treatment of Obese-Related Infertility: Personal Experience

The Relationship Between Anthropometric Measures, Blood Gases, and Lung Function in Morbidly Obese White Subjects

Conversion from Band to Bypass in Two Steps Reduces the Risk for Anastomotic Strictures

Do Patients Seeking Laparoscopic Adjustable Gastric Banding Surgery Differ from Those Seeking Gastric Bypass Surgery? A Comparison of Psychological Profiles Across Ethnic Groups